Dr Patty Mitre
Researcher biography
Dr María Patricia Hernández Mitre (Patty Mitre) is Postdoctoral Research Fellow in the Antimicrobial Optimisation Group led by Professor Jason Roberts and a member of the CRE-RESPOND (Centre of Research Excellence - REduce the burden of antimicrobial reSistance through oPtimal persONalised Dosing) team at the University of Queensland Centre for Clinical Research, located on the Royal Brisbane and Women's Hospital campus at Herston in Brisbane, Queensland, Australia.
She is certified in non-compartmental analysis (NCA) using Phoenix® WinNonlin™ and conducts NCA for Phase 1 clinical trials under NATA ISO 17025-accredited processes, preparing regulatory reports for submission to agencies such as the FDA. In addition, she develops and validates population pharmacokinetic models using Monolix®, Pmetrics™, and NONMEM® to optimise drug therapy and support therapeutic drug monitoring.
Dr Hernández Mitre is leading the individual pharmacokinetic analyses of antifungal therapies from the Screening Anti-Fungal Exposure in Intensive Care Units (SAFE-ICU) study. She also mentors students and clinicians, delivers training in pharmacokinetic modelling, and participates actively in university committees. She is experienced in clinical trial monitoring, regulatory writing, and electronic research data management.